These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 29377198)
1. Updates on obesity pharmacotherapy. Velazquez A; Apovian CM Ann N Y Acad Sci; 2018 Jan; 1411(1):106-119. PubMed ID: 29377198 [TBL] [Abstract][Full Text] [Related]
2. Current pharmacotherapy for obesity. Srivastava G; Apovian CM Nat Rev Endocrinol; 2018 Jan; 14(1):12-24. PubMed ID: 29027993 [TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for psychotropic drug-related weight gain. Howland RH J Psychosoc Nurs Ment Health Serv; 2008 Jul; 46(7):15-8. PubMed ID: 18686592 [TBL] [Abstract][Full Text] [Related]
4. [The pharmacotherapy of obesity]. Budai KA; Mirzahosseini A; Noszál Béla ; Tóth G Acta Pharm Hung; 2015; 85(1):3-17. PubMed ID: 26137782 [TBL] [Abstract][Full Text] [Related]
6. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease. Bays H Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacological therapy of obesity]. Pagotto U; Vanuzzo D; Vicennati V; Pasquali R G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755 [TBL] [Abstract][Full Text] [Related]
8. Medications for weight reduction. Bray GA Med Clin North Am; 2011 Sep; 95(5):989-1008. PubMed ID: 21855704 [TBL] [Abstract][Full Text] [Related]
9. New and emerging pharmacologic therapies for type 2 diabetes, dyslipidemia, and obesity. Taylor JR; Dietrich E; Powell JG Clin Ther; 2013 Jan; 35(1):A3-17. PubMed ID: 23328274 [TBL] [Abstract][Full Text] [Related]
10. Long-term pharmacotherapy for obesity. Klein S Obes Res; 2004 Dec; 12 Suppl():163S-6S. PubMed ID: 15687412 [TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy considerations in diabetes and obesity: setting patients up for success. Cornell S; D'Souza J Postgrad Med; 2014 Mar; 126(2):100-9. PubMed ID: 24685973 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic treatment options for obesity: what is old is new again. Ryan DH; Bray GA Curr Hypertens Rep; 2013 Jun; 15(3):182-9. PubMed ID: 23625271 [TBL] [Abstract][Full Text] [Related]
15. Long-term pharmacotherapy in the management of obesity. National Task Force on the Prevention and Treatment of Obesity. JAMA; 1996 Dec; 276(23):1907-15. PubMed ID: 8968018 [TBL] [Abstract][Full Text] [Related]
16. Treatment of overweight and obesity: lifestyle, pharmacologic, and surgical options. Cannon CP; Kumar A Clin Cornerstone; 2009; 9(4):55-68; discussion 69-71. PubMed ID: 19789064 [TBL] [Abstract][Full Text] [Related]
17. Treatment of the obese patient in primary care: targeting and meeting goals and expectations. Bray G; Look M; Ryan D Postgrad Med; 2013 Sep; 125(5):67-77. PubMed ID: 24113665 [TBL] [Abstract][Full Text] [Related]
18. Current updates in the medical management of obesity. Khan A; Raza S; Khan Y; Aksoy T; Khan M; Weinberger Y; Goldman J Recent Pat Endocr Metab Immune Drug Discov; 2012 May; 6(2):117-28. PubMed ID: 22435392 [TBL] [Abstract][Full Text] [Related]
19. New advances in models and strategies for developing anti-obesity drugs. Kim GW; Lin JE; Blomain ES; Waldman SA Expert Opin Drug Discov; 2013 Jun; 8(6):655-71. PubMed ID: 23621300 [TBL] [Abstract][Full Text] [Related]